First, the data of TCGA and GTEx databases showed that the expression of WEE2-AS1 was upregulated in glioma, and the results of RT-qPCR also demonstrated that the expression of WEE2-AS1 was upregulated in both glioma cells and tissue. Here, WEE2 is linked to central nervous system cancer.